# ACLS 101
## Bradycardia
1. Identify and treat underlying cause(s):
    1. Drugs (CCBs, BBs, digoxin), Ischemia, Electrolytes (e.g. hyperK)
    4. ABCs, monitored setting, pads on, IV access, 12-lead EKG
2. If stable, monitor and observe.
3. If unstable, give **atropine 1 mg IV bolus** q3-5 minutes, maximum of 3 mg.
4. If atropine ineffective, try pacing and/or one other medication.
    1. **Transcutaneous pacing**
    2. **Dopamine infusion** @ 5-20 mcg/kg/min
    3. **Epinephrine infusion** @ 2-10 mcg/min
5. May need expert consultation or transvenous pacing.

## Tachycardia
### Narrow Complex Regular
### Narrow Complex Irregular
### Wide Complex Regular
### Wide Complex Irregular

## Cardiac Arrest
### Shockable Rhythm
1. **Ventricular fibrillation**
2. **Pulseless ventricular tachycardia**

ACLS medications: (1) epinephrine 1 mg IV push q3-5 minutes, alternated with (2) amiodarone 300 mg (then 150 mg afterwards) IV

### Non-Shockable Rhythm
1. **Pulseless electrical activity**
2. **Asystole**

ACLS medications: (1) epinephrine 1 mg IV push q3-5 minutes

### Reversible Causes of Cardiac Arrest (5 H's and 5 T's)

| H's                | T's                    |
| ------------------ | ---------------------- |
| hypoxia            | thrombosis (pulmonary) |
| hydrogen ion       | thrombosis (coronary)  |
| hypovolemia        | tension PTX            |
| hyper/hypo-kalemia | tamponade              |
| hypothermia        | toxins                 | 

### Immediate Post-Cardiac Arrest (ROSC) Care
[Part 9: Post–Cardiac Arrest Care | Circulation (ahajournals.org)](https://www.ahajournals.org/doi/full/10.1161/circulationaha.110.971002)

1. **Ventilation and oxygenation**
    1. SpO2 >= 94%
    2. Do not hyperventilate: start at 10 breaths/min, titrate to PETCO2 35-45 mmHg
    3. Consider advanced airway and waveform capnography
2. **Treat hypotension**
    1. SBP >= 90 mmHg
    2. Reverse reversible causes (H's and T's)
3. **12-lead EKG**
    1. If STEMI or suspected AMI --> coronary reperfusion
4. **Does not follow commands** --> targeted thermal management 32°C to 36°C